RICHARD J BERMAN
CIK 1111620 · Chief Executive Officer · last filed 2025-01-07
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$1.77M
Companies
17
Total Filings
128
Lifetime Open-Market Net
-$6.79M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| BIVI | Director | 4,064 | $1.33 | $5.4K | -$198.7K | 8 | 2025-01-07 |
| CELUW | Director | 67,416 | $0.00 | $128 | $0 | 2 | 2025-01-06 |
| CNTX | Director | — | $0.59 | — | $0 | 3 | 2024-06-14 |
| CYRX | Director | 112,845 | $15.17 | $1.71M | -$4.70M | 31 | 2024-05-21 |
| COMSovereign Holding Corp. (COMSW) Delisted | Director | — | $0.01 | — | $0 | 1 | 2021-04-06 |
| Ontrak, Inc. (OTRKP) Delisted | Director | — | $0.37 | — | $0 | 1 | 2021-02-16 |
| Ayala Pharmaceuticals, Inc. (ADXS) Delisted | Director | — | $0.60 | — | $0 | 3 | 2020-05-05 |
| Ayala Pharmaceuticals, Inc. (ADXSW) Delisted | Director | 55,669 | — | — | $0 | 3 | 2018-06-27 |
| LISATA THERAPEUTICS, INC. (CLBS) Delisted | Director | 478 | $6.40 | $3.1K | $0 | 3 | 2017-01-31 |
| Ayala Pharmaceuticals, Inc. (ADXS.W) Delisted | Director | 66,430 | — | — | -$343.2K | 6 | 2016-08-10 |
| LISATA THERAPEUTICS, INC. (NBS) Delisted | Director | 38,766 | — | — | -$186.7K | 9 | 2015-06-04 |
| LISATA THERAPEUTICS, INC. (NBS.WS) Delisted | Director | 185,306 | — | — | -$270.1K | 8 | 2012-07-03 |
| EASYLINK SERVICES INTERNATIONAL CORP (ESIC) Delisted | Director | 82,006 | — | — | -$1.06M | 7 | 2011-08-02 |
| NEXM | Director | 22,656 | $2.12 | $48.0K | -$30.9K | 12 | 2010-04-01 |
| LISATA THERAPEUTICS, INC. (NBS.U) Delisted | Director | 137,728 | — | — | $0 | 1 | 2007-10-01 |
| EASYLINK SERVICES INTERNATIONAL CORP (ICCA) Delisted | Director | — | — | — | $0 | 1 | 2007-01-09 |
| DYADIC INTERNATIONAL INC (DIL) Delisted | Director | — | — | — | $0 | 1 | 2007-01-08 |
Recent Filings · Page 3 of 13
128 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-04-20 | BIVI | Grant (A) | — | $0 | EDGAR |
| 2021-09-29 | BIVI | Grant (A) | +1,600 | $0 | EDGAR |
| 2021-09-15 | CYRX | Mixed | — | -$1.20M | EDGAR |
| 2021-05-07 | CYRX | Grant (A) | — | $0 | EDGAR |
| 2021-04-09 | CYRX | Exer (M) | +27,789 | $363.7K | EDGAR |
| 2021-04-06 | — | Grant (A) | +250,000 | $0 | |
| 2021-04-06 | COMSovereign Holding Corp. (COMSW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-03-25 | CYRX | Exer (M) | +51,129 | $384.0K | EDGAR |
| 2021-03-01 | CYRX | Exer (M) | +21,082 | $100.0K | EDGAR |
| 2021-02-16 | Ontrak, Inc. (OTRKP) Delisted | Grant (A) | — | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.